Lab Tests Diagnostic Medical Tests Medical Lab Tests
 Red BLOOD CELLS
 Red blood cell count
 Hematocrit
 Red cell indices
   Erythrocyte
 sedimentation rate
 Reticulocyte count
 Osmotic fragility
   HEMOGLOBIN
 Total hemoglobin
 Fetal hemoglobin
 Hemoglobin
 electrophoresis
 Sickle cell test
 Unstable hemoglobin
 Heinz bodies
   Iron and total
 iron-binding capacity
 Ferritin
 Methemoglobin
   WHITE BLOOD CELLS
 White blood cell count
   White blood cell
 differential
   PLATELET ACTIVITY
 Bleeding time
 Platelet count
 Capillary fragility
 Platelet aggregation
   COAGULATION
   Activated partial
 thromboplastin time
 Prothrombin time
 Activated clotting time
   One-stage factor
 assay:Extrinsic
 coagulation system
   One-stage factor
 assay:Intrinsic
 coagulation system
 Plasma thrombin time
 Plasma fibrinogen
 Fibrin split products
 Plasma plasminogen
 Protein C
 Euglobulin lysis time
 D-Dimer
   International
 normalized ratio

Home :: Activated partial thromboplastin time

Activated Partial Thromboplastin Time

The activated partial thromboplastin time (APTT) is used to evaluate all the clotting factors of the intrinsic pathway - except platelets - by measuring the time required for formation of a fibrin clot after the addition of calcium and phospholipid emulsion to a plasma sample. An activator, such as kaolin, is used to shorten clotting time.

Purpose

  • To aid preoperative screening for bleeding tendencies.
  • To screen for congenital coagulation deficiencies of the clotting factors
  • To monitor heparin therapy

Patient preparation

  • Explain to the patient that this test is used to determine if blood clots normally.
  • Tell him that a blood sample will be taken. Explain who will perform the venipuncture and when.
  • Reassure him that drawing a blood will luke less than 3 minutes.
  • Explain that he may feel slight discomfort from the tourniquet pressure and the needle puncture.
  • When appropriate, tell the patient receiving therapy that this test may be repeated at regular intervals to assess the response to treatment.
  • inform the patient that food or fluids need not be restricted before the test.

Procedure and posttest care

  • Perform a venipuncture, and collect the sample in a 7-ml blue-top tube.
  • If a hematoma develops at the venipuncture site, apply warm soaks.
Precautions
  • Completely fill the collection tube, invert it gently several times, and send it to the laboratory on ice.
  • To prevent hemolysis, avoid excessive probing at the venipuncture site and handle the sample gently.
  • For a patient on anticoagulant therapy, additional pressure may be needed at the venipuncture site to control bleeding.

Reference values

Normally, a fibrin clot forms 21 to 35 seconds after addition of reagents. For a patient on anticoagulant therapy, ask the attending doctor to specify the reference values for the therapy being.

Abnormal findings

Prolonged APTT may indicate a deficiency of certain plasma clotting factors, the presence of heparin, or the presence of fibrin split products, fibrinolysins, or circulating anticoagulants that are antibodies to specific clotting factors

Interfering factors

  • Failure to fill the collection tube completely, to use the proper anticoagulant, or to adequately mix the sample and the anticoagulant.
  • Hemolysis due to rough handling of the sample or to excessive probing at the venipuncture site.
  • Failure to send the sample to the laboratory immediately or to place it on ice.

Diagnostic Medical Tests
Medical Tests
Dagnostic Tests
Lab Tests

Contact us | Link to us | Lab tests
Resources - 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
(c)Copyright Diagnostic-medical-tests.com All rights reserved.

The information provided on this web site should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. We will not be liable for any complications, or other medical accidents arising from the use of any information on this web site.